Kstandi
(Enzalutamide)
(40)
(112)
(Tablets)
Xtandi (enzalutamide) 40 mg 112 tab. ASTELAS Netherlands
Article:
In Stock
testimony
- Xtandi is indicated for the treatment of metastatic castration-resistant prostate cancer in adult men with disease progression during or after chemotherapy including docetaxel.
- Analogues: there are no known analogues. 1650ct / 155 / JKT
- Spelling errors: enzalutamide, kostandi, kastandi, ikstandi, Xtandi, enzalutamide
-
Commercial name:Kstandi
-
Сhemical name:Enzalutamide
-
Dosage:40
-
Quantity:112
-
Release form:Tablets
-
Производитель:Astellas
No reviews yet